Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2) [Phase 3]

View source ↗

Summary

Phase 3 trial OPTIMAL-BP 2 is currently recruiting to evaluate optimized blood pressure management after endovascular thrombectomy in acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yonsei University | Conditions: Acute Ischemic Stroke | Phase 3 | Status: RECRUITING